MeasuredReferenceIbrutinib targets ERBB4_HER4, TXK, BLK. Strongest hallmark effect: tumor promoting inflammation.
Top hallmarks
- tumor promoting inflammation4.3k
- evading apoptosis3.3k
- proliferation3.2k
Top pathways disrupted
- allograft rejection9.5k
- apical junction9.5k
- pi3k akt mtor signaling8.4k
Resistance landscape — Ibrutinib
MeasuredReference10 known oncogenic variants exist on Ibrutinib's top targets — see detail for inhibition impact.